PeptiDream Inc (PPTDF)
9.50
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
PeptiDream Price: 9.50 for April 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 18, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 17, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 16, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 15, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 12, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 11, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 10, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 09, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 08, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 05, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 04, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 03, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 02, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Apr 01, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Mar 28, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Mar 27, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Mar 26, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Mar 25, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Mar 22, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 205.00 |
Mar 21, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Mar 20, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Mar 19, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Mar 18, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Mar 15, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Mar 14, 2024 | 9.50 | 9.50 | 9.50 | 9.50 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.40
Minimum
Oct 31 2023
60.33
Maximum
Feb 11 2021
29.17
Average
23.82
Median
Price Benchmarks
Takeda Pharmaceutical Co Ltd | 13.19 |
Nxera Pharma Co Ltd | 9.72 |
Stemcell Holdings Inc | 0.06 |
Healios KK | 0.9399 |
AnGes Inc | 0.373 |
Price Related Metrics
PE Ratio | 59.38 |
PS Ratio | 6.082 |
Price to Book Value | 4.303 |
Price to Free Cash Flow | 15.65 |
Earnings Yield | 1.68% |
Market Cap | 1.231B |
Operating PE Ratio | 26.54 |
Normalized PE Ratio | 59.38 |